Skip to main content
logo
Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
1.655
-0.105 (-5.97%)
Jul 29, 2026, 12:36 PM EDT - Market open

BDTX Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
070----
Revenue Growth
------
Gross Profit
070----
Operating Income
-53.2712.52-78.78-86.46-92.83-126.87
Net Income
-43.2122.37-69.68-82.44-91.17-125.6
Earnings Per Share
-0.770.39-1.27-1.88-2.52-3.47
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
118.26128.6598.58131.4122.81209.79
Total Debt
14.0915.0718.7822.1925.328.14
Net Cash (Debt)
104.17113.5879.79109.2297.51181.65
Net Cash Growth
-22.56%42.35%-26.94%12.01%-46.32%-40.90%
Net Cash Per Share
1.831.971.452.482.685.02

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-34.0329.61-62.3-66.72-85.08-100.15
Capital Expenditures
----0.03-0.19-2.71
Free Cash Flow
-34.0329.61-62.3-66.75-85.27-102.86
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-100.00%----
Operating Margin
-17.89%----
Pretax Margin
-31.95%----
Profit Margin
-31.95%----
FCF Margin
-42.31%----

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-6.23----
P/FCF Ratio
-4.69----
PS Ratio
-1.98----